143 related articles for article (PubMed ID: 35258041)
21. Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea.
Yang E; Choi EJ; Park HS; Lee SO; Choi SH; Kim YS; Lee JH; Lee JH; Lee KH; Kim SH
Medicine (Baltimore); 2021 May; 100(20):e25448. PubMed ID: 34011022
[TBL] [Abstract][Full Text] [Related]
22. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
Kantarjian HM; Roboz GJ; Kropf PL; Yee KWL; O'Connell CL; Tibes R; Walsh KJ; Podoltsev NA; Griffiths EA; Jabbour E; Garcia-Manero G; Rizzieri D; Stock W; Savona MR; Rosenblat TL; Berdeja JG; Ravandi F; Rock EP; Hao Y; Azab M; Issa JJ
Lancet Oncol; 2017 Oct; 18(10):1317-1326. PubMed ID: 28844816
[TBL] [Abstract][Full Text] [Related]
23. Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital.
O'Hanley P; Easaw J; Rugo H; Easaw S
Am J Med; 1989 Dec; 87(6):605-13. PubMed ID: 2589395
[TBL] [Abstract][Full Text] [Related]
24. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
25. Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
Hallböök H; Lidström AK; Pauksens K
Infect Dis (Lond); 2016; 48(6):443-8. PubMed ID: 27030917
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.
Perl AE; Altman JK; Cortes J; Smith C; Litzow M; Baer MR; Claxton D; Erba HP; Gill S; Goldberg S; Jurcic JG; Larson RA; Liu C; Ritchie E; Schiller G; Spira AI; Strickland SA; Tibes R; Ustun C; Wang ES; Stuart R; Röllig C; Neubauer A; Martinelli G; Bahceci E; Levis M
Lancet Oncol; 2017 Aug; 18(8):1061-1075. PubMed ID: 28645776
[TBL] [Abstract][Full Text] [Related]
28. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia.
McCormick M; Friehling E; Kalpatthi R; Siripong N; Smith K
Pediatr Blood Cancer; 2020 Oct; 67(10):e28469. PubMed ID: 32710709
[TBL] [Abstract][Full Text] [Related]
30. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
DiNardo CD; Pratz KW; Letai A; Jonas BA; Wei AH; Thirman M; Arellano M; Frattini MG; Kantarjian H; Popovic R; Chyla B; Xu T; Dunbar M; Agarwal SK; Humerickhouse R; Mabry M; Potluri J; Konopleva M; Pollyea DA
Lancet Oncol; 2018 Feb; 19(2):216-228. PubMed ID: 29339097
[TBL] [Abstract][Full Text] [Related]
31. Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section.
Nabhan AF; Allam NE; Hamed Abdel-Aziz Salama M
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011876. PubMed ID: 27314174
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
Lo N; Cullen M
Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
[TBL] [Abstract][Full Text] [Related]
33. Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.
Stemler J; de Jonge N; Skoetz N; Sinkó J; Brüggemann RJ; Busca A; Ben-Ami R; Ráčil Z; Piechotta V; Lewis R; Cornely OA
Lancet Haematol; 2022 May; 9(5):e361-e373. PubMed ID: 35483397
[TBL] [Abstract][Full Text] [Related]
34. Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Al Omar S; Anabtawi N; Al Qasem W; Rihani R
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e131-e135. PubMed ID: 28234737
[TBL] [Abstract][Full Text] [Related]
35. Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfürt-Münster (I-BFM) study group.
Klein K; Hasle H; Abrahamsson J; De Moerloose B; Kaspers GJL
Br J Haematol; 2018 Oct; 183(1):87-95. PubMed ID: 30074239
[TBL] [Abstract][Full Text] [Related]
36. The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures.
Dimovska-Gavrilovska A; Chaparoski A; Gavrilovski A; Milenkovikj Z
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):85-97. PubMed ID: 28991759
[TBL] [Abstract][Full Text] [Related]
37. Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
Kadia TM; Reville PK; Borthakur G; Yilmaz M; Kornblau S; Alvarado Y; Dinardo CD; Daver N; Jain N; Pemmaraju N; Short N; Wang SA; Tidwell RSS; Islam R; Konopleva M; Garcia-Manero G; Ravandi F; Kantarjian HM
Lancet Haematol; 2021 Aug; 8(8):e552-e561. PubMed ID: 34329576
[TBL] [Abstract][Full Text] [Related]
38. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
Vehreschild JJ; Rüping MJ; Wisplinghoff H; Farowski F; Steinbach A; Sims R; Stollorz A; Kreuzer KA; Hallek M; Bangard C; Cornely OA
J Antimicrob Chemother; 2010 Jul; 65(7):1466-71. PubMed ID: 20410061
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic prophylaxis for preventing burn wound infection.
Barajas-Nava LA; López-Alcalde J; Roqué i Figuls M; Solà I; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Jun; (6):CD008738. PubMed ID: 23740764
[TBL] [Abstract][Full Text] [Related]
40. Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients.
May AK; Fleming SB; Carpenter RO; Diaz JJ; Guillamondegui OD; Deppen SA; Miller RS; Talbot TR; Morris JA
Surg Infect (Larchmt); 2006 Oct; 7(5):409-17. PubMed ID: 17083307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
